Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

News

Recruitment to higher dose corticosteroids closed for patients with hypoxia on no oxygen or receiving simple oxygen

Statement from the RECOVERY Chief Investigators

Paxlovid to be investigated by the RECOVERY Trial as a potential treatment for patients hospitalised with COVID-19

RECOVERY timeline

The RECOVERY Trial is two years old today

aerial shot of town in Ghana

RECOVERY Trial launches in Ghana

New RECOVERY trial result: baricitinib reduces deaths in patients hospitalised with COVID-19

Molnupiravir to be investigated by the RECOVERY Trial as a potential treatment for patients hospitalised with COVID-19

Lucy Fletcher and Richard Haynes

RECOVERY trial team members appointed MBEs

RECOVERY Trial to investigate whether higher doses of dexamethasone deliver greater benefit for patients with severe COVID-19

RECOVERY Trial to investigate sotrovimab as a possible treatment for hospitalised COVID-19 patients

Chris Hani Baragwanath Hospital, South Africa

RECOVERY Trial launches in South Africa

RECOVERY Trial wins ‘Oscar of Higher Education’ for STEM Research Project of the year

Peter Horby receives prestigious award for outstanding service to public health

RECOVERY Trial paper wins BMJ’s 2021 UK Research Paper of the Year Award

THE Awards

RECOVERY Trial nominated for ‘Oscar of higher education’

Empagliflozin to be investigated as a possible treatment for COVID-19 in the RECOVERY trial

The RECOVERY Trial was overall winner of the Project Management Institute’s 2020 Awards UK's Best COVID-19 Response Project 2020 Category.

RECOVERY Trial announced as overall winner of Best COVID-19 Response Project Award in the UK

RECOVERY Trial named joint winner of HDR UK’s Impact of the Year Award

RECOVERY trial finds Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response

Martin Landray and Peter Horby

RECOVERY Chief Investigators recognised in Queen’s Birthday Honours

RECOVERY trial finds aspirin does not improve survival for patients hospitalised with COVID-19

Load More